# Progentos Therapeutics, Inc. — Form D

Progentos Therapeutics, Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-17. The offering totals $68.6M, of which $68.6M was reported sold. Industry: Other.

## Offering

- Filed: 2024-05-17
- Form: D
- Accession: 0002014427-24-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $68.6M
- Amount sold: $68.6M
- Investors: 39
- Date of first sale: 2024-05-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-513638

## Issuer

- Name: Progentos Therapeutics, Inc.
- CIK: 0002014427
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 200 DEXTER AVENUE, WATERTOWN, MA, 02472
- Phone: 857-363-0218

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Cassidy Blundell | Director | Boston, MA |
| Dmitrij Hristodorov | Director | Boston, MA |
| Dan Janney | Director | Watertown, MA |
| Christopher Loose | Director | Watertown, MA |
| Aleks Radovic-Moreno | Director | Watertown, MA |
| Marc-Olivier Turgeon | Director | Watertown, MA |
| Christopher Loose | Executive Officer | Watertown, MA |
| Sanjay Magavi | Executive Officer | Watertown, MA |

## More

- [CIK 2014427 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2014427&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002014427-24-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.